Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting ...

Overall, 98,150 procedures (32%) met criteria for low-value care. Among these, 54,553 (56%) occurred between 2016 and 2019 ...

CKM syndrome, which links heart disease, kidney disease, diabetes, and obesity, is a fairly new concept. As a result, ...

With ACA subsidies ending in 2025, Ben Light explains how rising premiums may push individuals toward ICHRAs and reshape ...

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community ...

Panelists discuss how AML treatment has entered an exciting era of personalized medicine with increasing oral options and ...

Experts discuss the complexities of observing desmoid tumors, weighing the benefits of active surveillance against the need ...

The CAR T Vision Steering Committee has set an ambitious goal: to double the proportion of eligible patients treated with CAR T by 2030. 2 Reimbursement challenges stand out as an area where ...

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

Olomorasib combined with pembrolizumab showed significant efficacy in KRAS G12C-mutant advanced NSCLC, with a 57.1% objective response rate and 11.8 months median progression-free survival. The study ...

This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks.

An AJMC Stakeholder Interchange in Atlanta, Georgia addressed the need for collaboration to bring bispecific antibodies to the outpatient setting in multiple myeloma. Participants discussed the use of ...